Paola Papaldo

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi et al. · The Lancet · 2015 · 196 citations

Breast Oncology, Medicine, Dose-dense Chemotherapy +6

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Giulio Metro, Jennifer Foglietta, Michelangelo Russillo et al. · Annals of Oncology · 2010 · 167 citations

Neuro-oncology, Breast Oncology, Brain Metastases +9

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Giampietro Gasparini, Massimo Gion, Luigi Mariani et al. · Breast Cancer Research and Treatment · 2006 · 135 citations · Full text

Breast Oncology, Phase Ii Trial, Medicine +8

Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients

G. Ferretti, Alessandra Fabi, Paolo Carlini et al. · Oncology · 2005 · 132 citations

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

Alessandra Fabi, Anna Di Benedetto, Giulio Metro et al. · Clinical Cancer Research · 2011 · 98 citations